Adding Darolutamide Ups Survival in Metastatic Prostate Cancer
Risk for death lower with darolutamide versus placebo, combined with androgen-deprivation therapy and docetaxel
Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer
Rate of acute grade ≥2 genitourinary toxicity lower with MRI guidance versus CT guidance for SBRT in men with localized prostate cancer
Women Face Higher Risk for Severe AEs From Cancer Therapy
Large differences in risks for severe adverse events according to sex seen for cancer patients receiving immunotherapy
Patients Confused, Concerned About Diagnosis, Treatment of DCIS
In web-based survey, participants expressed concern about 'cancer spreading' or becoming invasive, not doing enough to prevent recurrence
New Billing Guidelines Do Not Ease Burden of EHR Documentation
Implementation of new guidelines did affect distribution of levels of service billed for evaluation and management patient visits
Daily Aspirin Does Not Prevent Recurrence of Breast Cancer
Compared with placebo, daily aspirin did not improve invasive disease-free survival in patients with high-risk, HER2-negative breast cancer
Brut, Sure Brand Deodorants Under Recall Due to Benzene
There have been no reports of adverse events related to the recall, which is being conducted out of an 'abundance of caution'
Scientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies
Prior Authorization Impacts Care, Workforce Productivity
AMA urges employers to ask insurers, employees about the impact of prior authorizations
Increase in Agricultural Use of 2,4-Dichlorophenoxyacetic Acid
Frequency of high 2,4-D levels in urine has increased, with elevated odds for children, women of childbearing age
